The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials
Open accessAbstract
We investigate whether private research investments are distorted away from long-term projects. Our theoretical model highlights two potential sources of this distortion: short-termism and the fixed patent term. Our empirical context is cancer research, where clinical trials—and hence, project durations—are shorter for late-stage cancer treatments relative to early-stage treatments or cancer prevention. Using newly constructed data, we document several sources of evidence that together show private research investments are distorted away from long-term projects. The value of life-years at stake appears large. We analyze three potential policy responses: surrogate (non-mortality) clinical-trial endpoints, targeted R&D subsidies, and patent design. (JEL D92, G31, I11, L65, O31, O34)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2019) · AEA Papers and Proceedings · doi:10.1257/pandp.109.612 · Cited by 10,902
Abiraterone and Increased Survival in Metastatic Prostate Cancer
de Bono, J. S., Logothetis, C. J., Molina, A., Fizazi, K., North, S., Chu, L., Chi, K. N., Jones, R. J., Goodman, O. B., Saad, F., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1014618 · Cited by 4,407
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Appropriating the Returns from Industrial Research and Development
Levin, R. C., Klevorick, A. K., Nelson, R. R., Winter, S. G., Gilbert, R., & Griliches, Z. (1987) · Brookings Papers on Economic Activity · doi:10.2307/2534454 · Cited by 3,772
Schmookler, J. (1966) · Harvard University Press eBooks · doi:10.4159/harvard.9780674432833 · Cited by 3,101
Efficient Capital Markets, Inefficient Firms: A Model of Myopic Corporate Behavior
Stein, J. C. (1989) · The Quarterly Journal of Economics · doi:10.2307/2937861 · Cited by 2,563
Optimal Investment, Monitoring, and the Staging of Venture Capital
GOMPERS, P. A. (1995) · The Journal of Finance · doi:10.1111/j.1540-6261.1995.tb05185.x · Cited by 2,053
Farber, S., Diamond, L. K., Mercer, R. D., Sylvester, R. F., & Wolff, J. A. (1948) · New England Journal of Medicine · doi:10.1056/nejm194806032382301 · Cited by 1,806
Identifying Technology Spillovers and Product Market Rivalry
(2013) · Econometrica · doi:10.3982/ecta9466 · Cited by 1,758
Agency, Information and Corporate Investment
Stein, J. C. (2003) · Handbook of the Economics of Finance · doi:10.1016/s1574-0102(03)01006-9 · Cited by 1,347
Cited by
The green economy transition: the challenges of technological change for sustainability
Söderholm, P. (2020) · Sustainable Earth · doi:10.1186/s42055-020-00029-y · Cited by 484
In the Shadow of a Giant: Medicare’s Influence on Private Physician Payments
Clemens, J., & Gottlieb, J. D. (2017) · Journal of Political Economy · doi:10.1086/689772 · Cited by 316
Race to the Bottom: Competition and Quality in Science
Hill, R., & Stein, C. (2025) · The Quarterly Journal of Economics · doi:10.1093/qje/qjaf010 · Cited by 40
Metadata
- Authors
- Budish, E., Roin, B. N., & Williams, H.
- Venue
- American Economic Review
- Publisher
- American Economic Association
- Published
- 2015-07-01
- Volume
- 105
- Issue
- 7
- Pages
- 2044-2085
- ISSN
- 0002-8282 (ISSN-L)
- OpenAlex
- W2107077262
- Cited by
- 302
- References
- 70
- FWCI
- 59.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials. https://app.cochat.ai/papers/10.1257/aer.20131176
- The paper
- Budish, E., Roin, B. N., & Williams, H. (2015). Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials. American Economic Review. https://doi.org/10.1257/aer.20131176
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.